To include your compound in the COVID-19 Resource Center, submit it here.

Transcept falls on expected delay for Intermezzo

Transcept Pharmaceuticals Inc. (NASDAQ:TSPT) fell $3.65 (42%) to $4.94 on Wednesday after saying it expects to

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE